Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism

Journal of Cell Biology

Volumn 133, Issue 3, 1996, Pages 683-693

  James, Payton L ^a,c   Stewart, Claire E H ^a   Rotwein, Peter ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Box 8231 ^*  (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C DERIVATIVE; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; TRANSGENE;

ANIMALS; ANTISENSE ELEMENTS (GENETICS); BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE; DNA, COMPLEMENTARY; EXTRACELLULAR MATRIX; GENE EXPRESSION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR I; MICE; MUSCLE FIBERS; MYOGENIN; PHENOTYPE; PLASMIDS; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSGENES;

ANIMALIA; RODENTIA;

EID: 0029994377     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.133.3.683     Document Type: Article

References (41)

1. Annweiler, A., R.A. Hipskind, and T. Wirth. 1991. A strategy for efficient in vitro translation of cDNAs using the rabbit β-glohin leader sequence. Nucleic Acids Res. 19:3750.
2. Bach, L.A., and MM. Rechler. 1995. Insulin-like growth factor binding proteins. Diabeies Rev. 3:38-60.
3. Bach, L.A., S. Hsieh, A.L. Brown, and M.M. Rechler. 1994. Recombinant human insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II-induced differentiation of L6A1 myoblasts. Endocrinology. 135:2168-2176.
4. Braun, T., G. Buschhausen-Denker, E. Bober, E. Tannich, and H.H. Arnold. 1989. A novel human muscle factor related to but distinct from MyoD1 induces myogenicconversion in 10T1/2 fibroblasts. EMBO (Eur. Mol. Biol. Organ.) J. 8:701-709.
5. Camacho-Hubner, C., W.H. Busby, Jr., R.H. McCusker, G. Wright, and D.R. Clemmons. 1992. Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. J. Biol. Chem. 267:11949-11956.
6. Chen, C.A., and H. Okayama. 1988. Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. BioTechmques. 6:632-638.
7. Chirgwin, J.M., A.E. Przybyla, R.J. MacDonald, and W.J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 24:5294-5299.
8. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
9. Davis, R.L., H. Weintraub, and A.B. Lassar. 1987. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell. 51:987-1000.
10. Edmondson, D.G., and E.N. Olson. 1990. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev. 4: 1450.
11. Edmondson, D.G., and E.N. Olson. 1993. Helix-loop-helix proteins as regulators of muscle-specific transcription. J. Biol. Chem. 268:755-758.
12. Ewton, D.Z., and J.R. Florini. 1995. IGF binding proteins-4, -5 and -6 may play specialized roles during L6 myoblast proliferation and differentiation. J Endocrinol. 144:539-553.
13. Florini, J.R., and K.A. Magri. 1989. Effects of growth factors on myogenic differentiation. Am. J. Physiol. 256:C701-C711.
14. Florini, J.R., and D.Z. Ewton. 1990. Highly specific inhibition of IGF-1-stimulated differentiation by an antisense oligodeoxyribonucleotide to myogenin mRNA. No effects on other actions of IGF-T. J. Biol. Chem. 265:13435-13437.
15. Florini, J.R., D.Z. Ewton, and S.L. Roof. 1991. Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression. Mol. Endocrinol. 5:718-724.
16. Florini, J.R., K.A. Magri, D.Z. Ewton, P.L. James, K. Grindstaff, and P.S. Rotwein. 1991. "Spontaneous" differentiation of skeletal myoblasts is de pendent upon autocrine secretion of insulin-like growth factor-II. J. Biol. Chem. 266:15917-15923.
17. Florini, J.R., D.Z. Ewton, and F.J. McWade. 1995. IGFs, muscle growth, and myogenesis. Diabetes Rev. 3:73-92.
18. Gonzalez-Sanchez, A., and D. Bader. 1984. Immunochemical analysis of myosin heavy chains in the developing chicken heart. Dev. Biol. 103:151-158.
19. Green, B.N., S.B. Jones, R.D. Streck, T.L. Wood, P. Rotwein, and J.E. Pintar. 1994. Distinct expression patterns of insulin-like growth factor binding proteins 2 and 5 during fetal and postnatal development. Endocrinology. 134:954-962.
20. Hossenlopp, P., D. Seurin, B. Segovia Quinson, and M. Binoux. 1986. Identification of an insulin-like growth factor-binding protein in human cerebrospinal fluid with a selective affinity for IGF-II. FEBS Lett. 208:439-444.
21. James, P.L., S.B. Jones, W.H. Busby, Jr., D.R. Clemmons, and P. Rotwein. 1993. A highly conserved insulin-like growth factor-binding protein (IGFBP-5) is expressed during myoblast differentiation. J. Biol Chem. 268:22305-22312.
22. Jones, J.I., and D.R. Clemmons. 1995. Insulin-like growth factors and their binding proteins - biological actions. Endocrine Rev. 16:3-34.
23. Jones, J.I., A.J. D'Ercole, C. Camacho Hubner, and D.R. Clemmons. 1991. Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I. Proc. Natl. Acad. Sci. USA. 88:7481-7485.
24. Jones, J.I., A. Gockerman, W.H. Busby, Jr., C. Camacho-Hubner, and D.R. Clemmons. 1993. Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J. Cell Biol. 121: 679-687.
25. Knudsen, B.S., P.C. Harpel, and R.L. Nachman. 1987. Plasminogcn activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells. J. Clin. Invest. 80:1082-1089.
26. Lassar, A.B., S.X. Skapek, and B. Novitch. 1994. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Opin. Cell Biol. 6:788-794.
27. Liu, J.-P., J. Baker, A.S. Perkins, E.J. Robertson, and A. Efstratiadis. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igflr). Cell. 75:59-72.
28. Mangiacapra, F.J., S.L. Roof, D.Z. Ewton, and J.R. Florini. 1992. Paradoxical decrease in myf-5 messenger RNA levels during induction of myogenic differentiation by insulin-like growth factors. Mol. Endocrinol. 6: 2038-2044.
29. McCusker, R.H., and D.R. Clemmons. 1988, Insulin-like growth factor binding protein secretion by muscle cells: effect of cellular differentiation and proliferation. J. Cell. Physiol. 137:505-512.
30. Melton, D.A., P.A. Krieg, M.R. Rehagliati, T. Manialis, K. Zinn, and M.R. Green. 1984. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 12:7035-7056.
31. Nam, T.J., W.H. Busby, Jr., and D.R. Clemmons. 1994. Human fibroblasts secrete a serine protease that cleaves insulin-like growth factor-binding protein-5. Endocrinology. 135:1385-1391.
32. Olson, E.N. 1993. Signal transduction pathways that regulate skeletal muscle gene expression. Mol. Endocritiol. 7:1369-1378.
33. Pinset, C., D. Montarras, J. Chenevert, A. Minty, P. Barton, C. Laurent, and F. Gros. 1988. Control of myogenesis in the mouse myogenic C2 cell line by medium composition and by insulin: characterization of permissive and inducible C2 myoblasts. Differentiation. 38:28-34.
34. Reeve, J.G., A. Guadano, J. Xiong, J. Morgan, and N.M. Blechen. 1995. Diminished expression of insulin-like growth factor (IGF) binding protein-5 and activation of IGF-I-mediated autocrine growth in simian virus 40-transformed human fibroblasts. J. Biol. Chem. 270:135-142.
35. Rosenthal, S.M., and Z.-Q. Cheng. 1995. Opposing early and late effects of insulin-like growth factor 1 on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts. Proc. Natl. Acad. Sci. USA 92:10307-10311.
36. Rotwein, P., S.K. Burgess, J.D. Milbrandt, and J.E. Krause. 1988. Differential expression of insulin-like growth factor genes in rat central nervous system. Proc. Natl. Acacl. Sci. USA. 85:265-269.
37. Rotwein, P., P.L. James, and K. Kou. 1995. Rapid activation of insulin-like growth factor binding protein-5 gene transcription during myoblast differentiation. Mol. Endocrinol. 9:913-923.
38. Sambrook, J., E.F. Fritsch, and T. Maniatis, editors. 1989. Plasmid vectors. In Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 1.3-1.110.
39. Silverman, L.A., Z.Q. Cheng, D. Hsiao, and S.M. Rosenthal. 1995. Skeletal muscle cell-derived insulin-like growth factor (IGF) binding proteins inhibit IGF-I-induced myogenesis in rat L6E9 cells. Endocrinology. 136: 720-726.
40. Stewart, C.E.H., and P. Rotwein. 1996. Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts. J. Biol. Chem. In press.
41. Tollefsen, S.E., R. Lajara, R.H. McCusker, D.R. Clemmons, and P. Rotwein. 1989. Insulin-like growth factors (IGF) in muscle development. Expression of IGF-I, the IGF-I receptor, and an IGF binding protein during myoblast differentiation. J. Biol. Chem. 264:13810-13817.